You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
堃博醫療-B(02216.HK):肺部影像處理軟件BRONCQCT®於中國獲批上市
格隆匯 03-21 22:40

格隆匯3月21日丨堃博醫療-B(02216.HK)發佈公告,公司的肺部影像處理軟件 BroncQCT® (下稱“本軟件”)正式獲得浙江省藥品監督管理局批準於中國上市。本軟件獲準上市反映集團一直致力於開發提升臨牀獲益的解決方案,並進一步鞏固公司於肺部疾病精準介入診斷及治療領域的地位。預計本軟件能夠提升醫生對肺部電腦斷層掃描(CT)影像的閱片效率,爲臨牀輔助診療提供強大助力,推動診斷過程更加高效及精準。

本軟件通過算法對CT影像進行處理,進行肺部的肺段分割與分析,實現量化數據可視化以及肺部結構的三維重建,爲專業醫生提供閱片報告,跨越多種應用,臨牀價值顯著。本軟件可用於在患者羣體中高效進行大範圍影像篩查,識別具有特定肺部特徵的患者。此外,本軟件支持對同一個患者的不同時期的影像進行分析,允許客觀比較及監控肺部參數隨時間的變化,從而優化臨牀工作流程的效率。聯合公司介入治療產品InterVapor®熱蒸汽治療系統及BroncAblate®智衡®射頻消融系統,提供肺部疾病篩查-診斷-治療全流程的解決方案,全方位守護患者肺部健康。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account